Alexander Seifalian, Professor of Nanotechnology and Regenerative Medicine worked at the Royal Free Hospital and University College London for over 26 years, during this time he spent a year at Harvard Medical School looking at caused of cardiovascular diseases and a year at Johns Hopkins Medical School looking at the treatment of liver cancer. He published more than 687 peer-reviewed research papers and registered 14 UK and International patents. On editorial boards of 41 journals. He supervised 121 PhD students, all successfully completed. He is currently CEO of NanoRegMed Ltd, working on the commercialisation of his research. During his career, Prof Seifalian has led and managed many large projects with successful outcomes in terms of commercialisation and translation to patients. In 2007 he was awarded the top prize in the field for the development of nanomaterials and technologies for cardiovascular implants by Medical Future Innovation, and in 2009 he received a Business Innovation Award from UK Trade & Investment (UKTI). He was the European Life Science Awards' Winner of Most Innovative New Product 2012 for the "synthetic trachea". Prof Seifalian won the Nanosmat Prize in 2013 and in 2016 he received the Distinguish Research Award in recognition of his outstanding work in regenerative medicine from Heals Healthy Life Extension Society. His achievements include the development of the world first synthetic trachea, lacrimal drainage conduit, and vascular bypass graft using nanocomposite materials, bioactive molecules and stem cell technology. Currently, he is working on the development and commercialisation of human organs using grapheme-based nanocomposite materials and stem cells technology. Recently he has commercialised a novel functionalised graphene oxide for medical and other industrial applications and synthetic grapheme-based nanocomposite materials for surgical and medical devices application. He is currently working on the development of facial organs, heart valves and tendons.

Dr. Dar-Jen Hsieh founded ACRO Biomedical Co., Ltd. in June 2014. The company is in the leading position of the field of collagen derived medical devices that expertizes in tissue engineering and regenerative medicine of human tissues and organs. Dr. Hsieh received his Ph.D in Cell and Molecular Biology from the State University of New York at Buffalo. He has years of experience in the biotechnology and healthcare field, and has held industrial, governmental, and academic positions.

Dr Serge Cosnier is currently Research Director exceptional class at CNRS at the Grenoble Alpes University (France) and the scientific director of the POLYNAT Carnot Institute. He received his doctoral degree in Chemistry from the Toulouse university (1982) and was an Alexander von Humbold postdoctoral fellow at the university of Munich, Germany. He is member of the Council of the Bioelectrochemical Society (2016-2023) and serves as Editor of Bioelectrochemistry, Specialty Chief Editor of Frontiers in Analytical Chemistry and Commissioning Editor for Electroanalysis. Dr Cosnier’s activity is focused on the molecular electrochemistry and bioelectrochemistry with the development of electrode materials whose applications include analytical chemistry with biological sensors (enzyme electrodes, immunosensors, aptasensors and DNA sensors), electrocatalysis, electrochemical biomimetic systems and energy conversion (biofuel cells and abiotic fuel cells). He has developed innovative conceptual advances in the field of electrogenerated organic polymers, inorganic nanostructured materials and 3D nanostructured electrode materials based on carbon nanotubes Dr Cosnier has authored over 380 peer reviewed publications (h-index 68). In 2009, he received the Katsumi Niki Prize of the International Society of Electrochemistry and was appointed as Fellow of this Society in 2010. In 2013, Dr Cosnier became a member of the Academia Europaea and was awarded in 2015 Doctor Honoris Causa of the University of Medicine and Pharmacy of Cluj-Napoca (Romania). Finally, he was elected member of the European Academy of Sciences (EurASc) in 2019 and Fellow of American Institute for Medical and Biological Engineering in 2021.

Professor Yung-Kang Shen received his Ph.D. degree from the National Taiwan University, Taipei, Taiwan, in 1995. He has been a Professor of the School of Dental Technology at Taipei Medical University (TMU) since 2014. He has been a Chairman of the School of Dental Technology of TMU since 2018. He is also the Director of Bio-Medical Nano/Micro Forming Lab of TMU, the Researcher of Nano Tissue Engineering and Image Research Center of Taipei Medical University Hospital (TMUH), the Researcher of Sleep Research Center of Taipei Medical University Hospital (TMUH), the Researcher of the Department of Otolaryngology of Taiwan Adventist Hospital (TAH). He is the Chairman of Taiwan Oral Biomedical Engineering Association, Co-Organizing Directors for Asia Pacific Society for Materials Research (APSMR), Co-Organizing Directors for Asia Pacific Society for Biology and Medical Sciences (APSBMS), the Supervisor of SME Taipei Chapter and the Director of Taiwan Society for Abrasive Technology. He is an Adjunct Professor of University Hasanuddin (Indonesia) since 2020. He is a Visiting Professor of Changchun University of Science and Technology (China) since 2012. He is a Part-time Professor of ShanDong University (China) since 2016. He is a Guest Professor of Zhejiang University of Technology (China) since 2017. Professor Shen is a project review committee member of the Ministry of Science and Technology (Taiwan). His research includes metamaterial, scaffold fabrication (PCL/graphene), 3D/4D/5D printing, biomedical nano/micro forming technology, medical bionics design and manufacturing, animal model for medicine therapy. Now, he has published more than 135 journal papers and 120 conference papers. Professor Shen has served as the keynote speaker or invited speaker at more than 28 international seminars. Professor Shen was awarded the Best Paper Award for the 3rd International Forum on Systems and Mechatronics in Singapore in 2010. He was also awarded the First Prize in Poster Presentation Award for the 2nd Research Week-International Symposium 2012 of COM on Dental Technology, Oral Health Care and Biomedical Device in Taipei in 2012. He was also awarded the Most Cited Article Award, 2012 to 2013 for "International Journal of Precision Engineering and Manufacturing" (SCI Journal). Professor Shen currently serves as the Editorial Board for Polymers (SCI Journal), Biology, Engineering and Medicine; Journal of Precision Medicine and Public Health; Open Access Journal of Science and Technology; International Open Access Journal of Translational Medicine and International Journal of Manufacturing Engineering.

Dr. Gramatiuk Svetlana, MD, PhD, she is graduate of Kharkiv National Medical University. She studied biobanking at the University of Medical University Graz, Austria and infection diseases in medicine and virusology, microbiology and allergology at the Kharkiv National Medical University. In her practice Svetlana specializes in the care of metabolic diseases and oncology patients. Dr. Gramatiuk's interests also include mitochondrial complex in stem cell and regenerative medicine, and Svetlana is a clinical associate professor of pathophysiology at Medical Post-graduation Institute. In 2017 she was appointed the President of Ukraine Association of Biobank. Dr. Gramatiuk will soon complete 15 years in academic medicine in Kharkiv and she continues to train medical students and residents in bio banking, pathophysiology and infection diseases. Her main goal is to teach the art and practice of biobank with the ultimate goal of graduating the best and most caring doctors possible.

Will be updated soon...

Professor Raman Singh's primary research interests are in the relationship of Nano-microstructure and Environment-assisted degradation and fracture of metallic and composite materials, and Nanotechnology for Advanced Mitigation of such Degradations. He has also worked extensively on use of advanced materials (e.g., grapheme) for corrosion mitigation, stress corrosion cracking, and corrosion and corrosion-mitigation of magnesium alloys (including for the use of magnesium alloys for aerospace, defence and bioimplant applications). He is a senior professor at Monash University, Australia. He was a Visiting Professor at ETH Zurich, Switzerland, US Naval Research Lab, and University of Connecticut. He worked as a scientist at Indian Atomic Energy and as and a post doc University of New South Wales, Australia. Prof Singh's professional distinctions and recognitions include: Guest Professor of ETH Zurich, Editor of a book on Cracking of Welds (CRC Press), Lead Editor of a book on Non-destructive Evaluation of Corrosion (Wiley), Editor-in-Chief of an Elsevier and two MDPI journals, leader/chairperson of a few international conferences and regular plenary/keynote lectures at international conferences, over 250 peer-reviewed international journal publications and 15 book chapter, and several competitive research grants (that includes 4 Discovery, 7 Linkage and one ITRH grants of Australian Research Council). Prof Singh has supervised 50 PhD students. His vibrant research group at Monash University comprises of PhD students from different disciplines (Mechanical, Chemical, Materials and Mining Engineering, and Science) as well as from different cultural backgrounds (Australian, Middle-eastern, Chinese, Malaysian, Indian, African, North American and Israeli).

Will be updated soon...

Aline is currently Professor of Biomolecular Engineering and Associate Dean for Business Engagement and Innovation at the University of Manchester. She is a chemist by training having gained her BSc from Strathclyde University and her PhD from Durham University in 2000. She went onto hold a New Hall College Junior Research Fellowship in the Cavendish Laboratory, Cambridge University before joining Manchester as Lecturer in 2002. Aline’s research interests lie at the life-science interface with emphasis on applying physical principles to mimic, manipulate and improve biomolecular self-assembly for material design and application. In this area she has published over 100 refereed papers, authored 5 patents and has won > £8M from research councils, EU, charities and industry to support her research group. She has also won several awards over the years including the 2014 Philip Leverhulme Prize for Engineering and Finalist for the NW Great British Entrepreneur 2021. Some of her work is now being commercialised through Manchester BIOGEL Ltd; a Start-Up she co-founded in 2014 which licences IP and know-how from the University. Over the past two years, under her leadership as CEO, the company has raised £4M in investment from Venture Capital, Private and Catapult Venture Funds, grown from 1 to 9 full time staff, won 2 Innovate grants, initiated 11 CASE PhD studentships across the UK & Ireland, launched 5 new products and doubled its financial revenues over the past three financial years. This led to the company being listed as one of the Top 10 BioTech Start-Ups in Europe by Start-Up City in 2021.

Prof. h.c. Karine Sargsyan, MD was born in Armenia and lives in Graz, Austria. She is Managing Director for International Biobanking and Education at the Medical University of Graz and Vice Scientific Leader and Lecturer of the course MSc Biobanking at the Medical University of Graz. Due to her professional experience, she is a highly appreciated member of many scientific organizations such as ISBER (International Society for Biological and Environmental Repositories), the Austrian Society for Epidemiology and ESBB (European, Middle Eastern & African Society for Biopreservation and Biobanking). She provides scientific expertise and experience as a consultant to several institutional organizations (ACC – ILCEC: Oncology Research Vietnam, Qatar Biobank, etc.). In her free time, she enjoys painting (three exhibitions), playing the piano and happily commits herself to various voluntary activities.

After graduating from Yeditepe University Genetics and Bioengineering Department in 2014, I was accepted as a research assistant at the Harvard- MIT Division of Health Science and Technology (HST), Harvard Medical School, Brigham and Women’s Hospital, Khademhosseini Lab, Cambridge, MA on a 1-year project about the development of next generation anti-cancer drug based on multi-functional Salmonella using tumor-on-a-chip test platform. In addition, I also worked on a project aiming at promoting the polarization of macrophages towards an M2 phenotype in micropatterned 3D hydrogels. Before obtaining my M.Sc degree, I worked as a flow cytometry specialist at the Center for Regenerative Medicine and Stem Cell Research & Manufacturing at Liv Hospital, Istanbul, Turkey. My responsibilities included implementing cell culture techniques, performing flow cytometry analysis, genetic analysis, gene expression analysis, telomerase activity tests and mycoplasma detection of the biological products (cell/tissue products) produced in the GMP (Good Manufacturing Practices) laboratories, before application to the patients. I completed my M.Sc. degree in Biotechnology at Yeditepe University between 2015-2017 with a high honors degree. My thesis study focused on developing nanoparticles for intracellular BIKDDA delivery for the treatment of prostate cancer (Kocak, P., Oz, U. C., Bolat, Z. B., Ozkose, U. U., Gulyuz, S., Tasdelen, M. A., ... Telci, D. (2020). The utilization of poly(2-ethyl-2-oxazoline)-b-poly(ε-caprolactone) ellipsoidal particles for intracellular BIKDDA delivery to prostate cancer. Macromolecular Bioscience, e2000287). During my Ph.D. training, I started working on exosomes and exosome engineering and I am one of the inventors of an international patent on the use of plant derived exosomes for the treatment of small cell lung cancer for the first time (US Patent 10,881,706, 2021). I also worked on the effect of wheat derived exosomes on wound healing during my Ph.D. thesis. I was also involved in various projects which concentrated on the development of therapeutic approaches with using exosomes and engineered exosomes. During my Ph.D. training, I joined Dr. Su Ryon Shin's group at BIRC Division of POLEN KOÇAK Engineering in Medicine at BWH, Harvard Medical School, as a visiting researcher (2019-2020). Within this group, I mainly focused on the ongoing research related to cardiac reprogramming using miRNA loaded exosomes, liposomes and hybrid nanoparticles. By actively participating in this project, I had a chance to enrich my professional development in areas needed for successful collaboration with other disciplines besides strengthening the interdisciplinary contributions and capabilities. Consequently, I believe I have gained a profound knowledge of experimental and theoretical concepts of tissue Engineering which will enable me to perform sophisticated experiments and interpret the data. Lastly, I am the co-founder of Genestetix Biotechnology which is an R&D start up that develops artificial intelligence-supported personalized genetic test kits and personalized biotechnological products within the Incubation Center of Acıbadem University. I am also one of the founding members of the Artificial Intelligence and Technology Association in Turkey.

Giorgiana M. Cătunescuhas been a faculty member at the University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca, Romania, for 13 years. She was an EU-FORA Fellow (2018-2019) in the Nutrition and Bromatology, Toxicology and Legal Medicine Department, Faculty of Pharmacy, University of Seville working on chemical risk assessment. She delivers lectures and practical seminars for: Food Industry Equipment and Facilities, Food Equipment Management, Agri-Food Marketing, Biological hazard assessment and control in food quality management, while her research activities include microbiology, food biotechnologies, preserving methods, food industry process design, food risk assessment. She was principal investigator in 7 research grants and a collaborator researcher in another 6. Shehas published 1 scientific book; 4 chapters in international books; 20 articles in ISI journals; more than 20 articles in journals indexed international data bases (IBD); more than 30 short-communications conference proceedings.

I received education from a medical background, which provided me with experimental and theoretical knowledge in understanding the cause, pathophysiological progress, and corresponding clinical diagnosis and treatment approaches. Additionally, I received my scientific research training at North Carolina State University and Duke University. Currently, I am an assistant research professor in the Department of Molecular Biomedical Sciences at North Carolina State University. My research focuses on investigating the use of stem cells and stem cell-derived particles for developing regenerative therapeutics. Additionally, I have been focused on animal cardiac disease models and translational medicine that will aid in the development and execution of this study. I plan to continue my research on developing novel treatments for cardiac disease.

Dena Shahriari is an Assistant Professor at the University of British Columbia at the department of Orthopaedics and the School of Biomedical Engineering and is a Principal Investigator at the International Collaborations on Repair Discoveries where she is the director of the BioAugmentative Interfaces Laboratory. She obtained her bachelor in bioengineering from UC Berkeley, was a recipient of the US National Science Foundation Graduate Award and completed her PhD in Macromolecular Science and Engineering at the University of Michigan. She then moved on to MIT at the Bioelectronics laboratory with Prof. Polina Anikeeva for her postdoctoral work as a Craig Neilsen Spinal Cord Injury Postdoctoral Fellow. Prof. Shahriari's laboratory develops smart biomaterials and bioelectronic devices to restore motor and organ function after injuries and diseases.

Will be updated soon...

Chairperson of Natural Resources and Environmental Department, Assistant Professor of Environmental Engineering, College of Graduate Studies, Arabian Gulf University. PhD.& MPhil. in Engineering specializing in Environmental Engineering and Sustainability,WMG, University of Warwick, UK, MSc. in Environmental Management from AGU. High Diploma & PGCin Bio-system Sustainability as a Japanese Government fellow, Hokkaido University, Sapporo, Japan. BSc. in Biology, University of Bahrain Selected as one of the most 3 women influencers in the Middle East in the field of Science and Technology for 2020 by Women News Agency, 2021. Representative of west Asia in the GO4SDGs UN global initiative. UNEP Sustainability Advisor.Winner of Venus International Women Award 2021 (Outstanding Woman Achiever in Environmental Engineering and Sustainability), Venus International Women Award 2016 (Outstanding Women Achiever). ECO-MENA role model for Arab Women who made typical contributions in the field of Waste Management in their countries. Laureate of LO'REAL-UNESCO Pan-Arab Regional Fellowship Award "For Women in Science 2013. Brand AmbassadorofABC and SEWA 2018, UAE. Member in EUROMA & EIASM, UN-ESCWA expert group. Speaker in local, regional and international Conferences.Volunteer in environmental events. Published scientific papers and book chapters on waste management, waste-to-energy technologies, bioenergy, public awareness, socio-economic analysis. Founder and coordinator of Professional Certificate of Waste Management program. Contribute in many regional environmental projects. Editorial board member in open access journal "Advances in Earth and Environmental Science". Active reviewer of high impact "ENERGY" journal by Elsevier.